NEW YORK -- Prices of laboratory monkeys in the U.S. have jumped around 15-fold from pre-COVID levels, with China having blocked exports and a new stable source yet to be found.
The shortage could delay development by American pharmaceutical manufacturers, making the problem a matter of national economic security.


%2520%E3%81%AE%E3%82%B3%E3%83%94%E3%83%BC.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)

